Services et fabrication de Pama

Discover our services and our manufacturing

We make patients and health users our priority


EtO sterilization

  • EtO sterilization :

Ethylene oxide sterilization, known by the abbreviations EO and EtO, is the method having general compatibility with a large number of materials, resins and types of medical instruments. Through a gas diffusion process, ethylene oxide can sterilize the products and eliminate any viable microorganisms. We use this method for its efficiency and environmental performance. PAMA has chosen to use an absorption system with an efficiency of 99.95% rather than using a catalytic burner, which represents the norm in the industry, and the combustion of hydrocarbons associated with it.

EO sterilization is suitable for:

  • Polymer resin-based products;

  • Single-use medical devices;

  • Procedural kits;

  • Surgical trays;

  • Synthetic shirts;

  • External terminal sterilization of sealed devices combining a device and drugs (filled syringes, impregnated stents).


Why use this process?

  • It sterilizes at low temperature, which guarantees the integrity of the product and the packaging;

  • It effectively sterilizes a wide range of polymers of resins, natural materials and metals, as well as products combining drugs and devices that require sterilization of the surface by external contact;

  • It consistently meets product and regulatory requirements;

  • It effectively sterilizes a wide range of products with different variations of dosage, density and package size requirements;

  • It allows the parametric release of products directly after processing, which results in a reduction in waiting time to accelerate the time to market of the product.


Would you like to know how EO sterilization services can be applied to your products?

Covid 19

PAMA swab supply chain

PAMA Manufacturing and Sterilization has partnered with HP Canada and its consortium of 11 small businesses across Canada, which specialize in 3D printing and digital manufacturing, to support national requirements for personal protective equipment ( PPE) and COVID-19 testing.

3DP swabs have passed the clinical trials sanctioned by Health Canada. In the meantime, HP and its partners, including PAMA, have worked with other countries outside of Canada, such as the United States, Belgium, France, Norway and Spain as well as with organizations well known, such as the US military, for delivering millions of 3DP swabs.

These swabs have received regulatory approval from Health Canada (IO # 314006).

PAMA aims to support our country's COVID-19 testing requirements by producing up to 100 million nasopharyngeal swabs per year using HP's 3D printing technology (3DP). Swabs can be packaged individually or as part of a kit with transport media (PBS or VTM).


PAMA will lead its own swab supply chain and be responsible for the final efforts: sterilization, packaging, quality control and delivery.

Conclusion of the clinical study:

  • RT-PCR Diagnostic Test Performance Agreement: The actual positive percent agreement is 93.90% .

  • Ability to take a sample (RNase P): Swabs are similar in their ability to take a sample.

  • User-friendliness: The nasopharyngeal swabs (SWB-0007) manufactured by PAMA are comparable to other swabs available in the market, in terms of user characteristics, ability to collect a sample and agreement of test results.

Marque privée de Pama

Private label

We are able to make all the medical kits for you that will meet your needs.

Contact us to design your own custom kit.

Consultation et formation de Pama

Consulting and training

We offer a consultation and training service on request. This service is offered for companies who are new to the market and who need support at the regulatory level and at the level of medical market standards.

More specifically, we are able to support you on the following points:

  1. Development of sterilization cycles

  2. Validation of sterilization cycles (in accordance with ISO 11135)

  3. Performing routine sterilization

  4. Health Canada medical device establishment licenses.

  5. ISO 14644-1: 2015 Class 7 - Cleanrooms and associated controlled environments - Part 1: Classification of particulate air cleanliness.

  6. ISO 13485: 2016 Medical devices - Quality management systems - Requirements for regulatory purposes.

  7. ISO 11135: 2014 - Sterilization of health care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process for medical devices.

  8. ISO 14971: 2019 Application of risk management to medical devices

  9. DEL (Drug Establishment Licenses)

  10. 21 CFR Part 820 - Quality system regulation.